{"id":"W2784115121","doi":"10.1038/nrcardio.2017.223","title":"Reversal agents for non-vitamin K antagonist oral anticoagulants","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Idarucizumab; Dabigatran; Medicine; Rivaroxaban; Edoxaban; Apixaban; Vitamin K antagonist; Intensive care medicine; Pharmacology; Anesthesia; Warfarin; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001074331,0.0009096066,0.002833046,0.002938046,0.0002367068,0.00141311,0.001161754,0.0019189,0.005430138],"category_scores_gemma":[0.003901948,0.0003493582,0.001403161,0.001507704,0.0004729351,0.001693848,0.0007188267,0.002677949,0.00133459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005050788,"about_ca_system_score_gemma":0.001211958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007883681,"about_ca_topic_score_gemma":0.002019392,"domain_scores_codex":[0.999317,0.0001256239,0.0002408125,0.00009207665,0.0001840521,0.00004042953],"domain_scores_gemma":[0.9979793,0.001252032,0.0004888881,0.00003516451,0.0001913455,0.00005337204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002393834,0.00008399452,0.0001605462,0.05978106,0.0005320944,0.0001662188,0.00004993564,0.0001101515,0.0006935519,0.001248087,0.0245766,0.9123584],"study_design_scores_gemma":[0.0006385905,0.000625224,0.00201019,0.05002706,0.003554029,0.002614087,0.0001007407,0.0002056939,0.0006773617,0.002236616,0.9372422,0.0000681765],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005565941,0.999256,0.00004876313,0.0001789157,0.0001480073,0.000004854067,0.00001264681,0.000004515453,0.0002905783],"genre_scores_gemma":[0.0007982075,0.9978276,0.0001953001,0.0005155905,0.0003659746,0.00001096233,0.00002681979,0.000001796403,0.0002576676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005430138,"threshold_uncertainty_score":0.01816559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1687558604068853,"score_gpt":0.4623731280509875,"score_spread":0.2936172676441021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}